Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 82 of 95, showing 5 Applications out of 474 total, starting on record 406, ending on 410

# Protocol No Study Title Investigator(s) & Site(s)

406.

ECCT/23/09/05   LCCC 2236 Study
    LCCC  2236: Phase I study of self-administered Artesunate pessaries (vaginal inserts) for treatment of cervical precancer in HIV positive and HIV-negative women in Kenya    
Principal Investigator(s)
1. Chemtai Mungo
2. Jackton Omoto
Site(s) in Kenya
FACES, Lumumba Sub-county Hospital
 
View

407.

ECCT/14/08/03   STAND Study (Shortening Treatment by Advancing Novel Drugs)
    Long Title:   A Phase 3 Open Label Partially Randomised Trial to Evaluate the Efficacy, Safety and Tolerability of the Combination of Moxifloxacin plus PA-824 plus Pyrazinamide after 4 and 6 months of Treatment in Adult Subjects with Drug Sensitive Smear Positive Pulmonary Tuberculosis and after 6 months of Treatment in Adult Subjects with Multi-Drug Resistant, Smear-Positive Pulmonary Tuberculosis       Short Title:   STAND Study (Shortening Treatment by Advancing Novel Drugs)   
Principal Investigator(s)
1. Dr Videlis Nduba
2. Dr Evans Amukoye
Site(s) in Kenya
1. KEMRI-CRDR(East Nairobi) (Nairobi City county)
2. KEMRI-CRDR(West Nairobi) (Nairobi City county)
 
View

408.

ECCT/23/05/07   LATA
    Long-Acting Treatment in Adolescents (LATA) A randomised open-label 2-arm 96 week trial in virologically suppressed HIV-1-positive adolescents aged 12-19 years of age in Sub-Saharan Africa   
Principal Investigator(s)
1. Abraham Siika
Site(s) in Kenya
1.
 
View

409.

ECCT/24/03/05   221163 PALISADE
    Long-Term Follow-Up of CAB LA for Participants in HPTN 083 and HPTN 084 CAB PrEP Studies at Risk of HIV Acquisition   
Principal Investigator(s)
1. Grace Mboya
Site(s) in Kenya
KEMRI Kisumu Clinical Research Site
 
View

410.

ECCT/19/08/02   LOxaF- N Trial
    LOW DOSE OXYTOCIN AS AN ADJUNCT TO FOLEY CATHETER FOR CERVICAL RIPENING IN NULLIPAROUS WOMEN AT MTRH, ELDORET, KENYA: A RANDOMISED CONTROLLED TRIAL.   
Principal Investigator(s)
1. Patrick Omondi Otieno
Site(s) in Kenya
The Riley Mother and Baby Hospital (RMBH) at Moi Teaching and Referral Hospital (MTRH) in Eldoret, Kenya.
 
View